AstraZeneca says data from Covid-19 vaccine's phase-1 trials to be out soon

Once the late stage trials begin, the company simultaneously will start working on the global manufacturing capabilities.

AstraZeneca, which has entered into a partnership with University of Oxford to develop a potential vaccine aimed at preventing Covid-19 infection, has said the data from phase-I trials will be available in a month and advancement to late-stage trials should take place by the middle of this year.
 

Once the late-stage trials begin, the company will simultaneously start working on global manufacturing capabilities. It will leverage all the manufacturing sites available globally after the vaccine compound is proven to be successful.

“If the vaccine is found to be effective and safe, the most important responsibility would be to make it available